CIK: 0001318153
Total reported value
$2.9M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BSM | Black Stone Minerals LP | Stock-Other | 54.54% | — | +0.15% | |
| 2 | ZNTL | Zentalis Pharmaceuticals INC | Stock-Other | 22.48% | — | +0.00% | |
| 3 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 8.59% | — | -81.79% | |
| 4 | UBXGBUSD | Unity Biotechnology INC | Stock-Other | 8.45% | — | — | |
| 5 | ✓ | Evelo Biosciences INC | Stock-Other | 3.97% | — | — | |
| 6 | ✓ | Biosig Technologies Inc New | Stock-Other | 0.77% | — | -35.49% | |
| 7 | EXK | Exact Sciences CORP | Stock-Materials | 0.52% | — | — | |
| 8 | CLPT | Clearpoint Neuro INC | Stock-Other | 0.40% | — | — | |
| 9 | ✓ | Cancer Genetics INC | Stock-Other | 0.29% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BSM | Black Stone Minerals LP | +11.8% | +0.15% | Add |
| 2 | ✓ | Biosig Technologies Inc New | +5.6% | -35.49% | Trim |
| 3 | CLPT | Clearpoint Neuro INC | +3.3% | — | Unchanged |
| 4 | ✓ | Evelo Biosciences INC | +1.2% | — | Unchanged |
| 5 | ✓ | Cancer Genetics INC | +0.3% | — | Unchanged |
| 6 | ZNTL | Zentalis Pharmaceuticals INC | -0.8% | +0.00% | Add |
| 7 | UBXGBUSD | Unity Biotechnology INC | -5.7% | — | Unchanged |
| 8 | SPY | Ss Spdr S&p 500 ETF Trust-us | -19.3% | -81.79% | Trim |
| 9 | EXK | Exact Sciences CORP | — | NEW | New buy |
| 10 | MCRB1EUR | Seres Therapeutics INC | — | EXIT | Sold out |